Brian Seal, PhD

Articles by Brian Seal, PhD

Adherence to Inhaled Corticosteroid Use and Local Adverse Events in Persistent Asthma

ByJasmina I. Ivanova, MA,Howard G. Birnbaum, PhD,Matthew Hsieh, BA,Andrew P. Yu, PhD,Brian Seal, PhD,Thys van der Molen, PhD,Srinivas Emani, PhD,Richard A. Rosiello, MD,Gene L. Colice, MD

December 1st 2008

This study evaluated the association between patient-reported and medical record–abstracted local adverse events and patient-reported and claims-based adherence to inhaled corticosteroid therapy.

Latest Updated Articles

Adherence to Inhaled Corticosteroid Use and Local Adverse Events in Persistent Asthma
December 1st 2008

Brian Seal, PhD

Articles by Brian Seal, PhD

Adherence to Inhaled Corticosteroid Use and Local Adverse Events in Persistent Asthma

Latest Updated Articles

Trending on AJMC

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD

frontMIND Trial Shows PFS Benefit With Tafasitamab, Lenalidomide Combo in High-Risk DLBCL: Umberto Vitolo, MD